Skip to content
April 17, 2024

Equity.Guru

Investment information for the new generation

Search

Canadian shroom-stocks

Cruel, cruel summer It’s near the end of September and the seasons are changing.   Chet Hanks predicted this past summer would be a ‘white boy summer’. But for…
Biting the hand that feeds you Nova Mentis Life Sciences (NOVA.C) director Steven Feldman has some interesting thoughts around vaccines, and as a life sciences company, I think it’s…
Novamind (NM.CN) is a company that addresses mental health. Utilizing a network of psychiatry clinics, research sites and therapeutic retreats specialized in psychedelic medicine. The company states they are…
Researching Filament Health (FH.NE) taught me a lot about the psychedelic space and shroom stocks. As someone who is big on eating clean and organic food, it came to…
The NYSE   Cybin (CYBN.N) just finished its first trading day on the New York Stock Exchange (NYSE) after announcing the upcoming uplisting last month. It was a less…
MAPS, FDA & Health Canada In a highly regulated sector like psychedelics, governing bodies like the FDA and Health Canada have the power to shape and influence how an…
Mushroom enthusiasts Filament Health (FH.NE) is looking at mushroom compounds far beyond just psilocybin as the company is run by actual mushroom enthusiasts with access to a lot of…
Magnifying the problem   When lockdowns first hit back in March 2020 I was pretty sure the capital markets and the psychedelic sector would suffer. It was a burgeoning…
+326% wtf? PharmaTher (PHRM.C), the Vancouver-based psychedelics company is on an impressive run. In the last month, the stock has rocketed from $0.19 CAD up to $0.81 CAD, a…
Multiple pivots Mind Cure (MCUR.C) began as a mushroom nootropic deal that has since shifted to ibogaine production and the development digital platforms. The company has been able to…